Hem › Juvenil myelomonocyt leukemi › Minnesota
Kliniska studier för Juvenil myelomonocyt leukemi i Minnesota
4 studier för Juvenil myelomonocyt leukemi söker deltagare vid platser i Minnesota.
Städer i Minnesota
Officiell studietext (engelska)
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- University of Minnesota/Masonic Cancer Center, Minneapolis
RekryterarFas 1
Ålder 1 till 18 · Alla kön · Uppdaterad 25 aug. 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Masonic Cancer Center at University of Minnesota, Minneapolis
RekryterarFas 2
Upp till ålder 60 · Alla kön · Uppdaterad 25 juni 2026 · NCT03314974MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- University of Minnesota Masonic Cancer Center, Minneapolis
RekryterarFas 2
Upp till ålder 60 · Alla kön · Uppdaterad 6 apr. 2026 · NCT05735717Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.